HomeCOGT • NASDAQ
Cogent Biosciences Inc
add
$12.72
2.91%
After Hours:(0.00%)0.00
$12.72
Closed: Sep 18, 4:02:20 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 75.58M | 17.39% |
Net income | -73.53M | -24.73% |
Net profit margin | — | — |
Earnings per share | -0.53 | 10.17% |
EBITDA | -74.93M | -17.48% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 237.85M | -34.52% |
Total assets | 274.82M | -36.08% |
Total liabilities | 119.78M | 111.21% |
Total equity | 155.04M | — |
Shares outstanding | 139.78M | — |
Price to book | 30.15 | — |
Return on assets | -67.65% | — |
Return on capital | -83.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -73.53M | -24.73% |
Cash from operations | -54.54M | -27.73% |
Cash from investing | 8.91M | 110.53% |
Cash from financing | 47.23M | 18,548.05% |
Net change in cash | 1.60M | 101.25% |
Free cash flow | -27.57M | -3.60% |
Previous close
$12.36
Day range
$12.33 - $12.75
Year range
$3.72 - $13.50
Market cap
1.78B USD
Avg Volume
1.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Headquarters
Website
Employees
205
